2022 annual financial data
Oncolytics Biotech 2022 Financial results
Direct answer
Revenue was 0 CAD.
Operating income was -19,837,901 CAD and net income was -18,298,703 CAD.
Operating cash flow was -17,208,222 CAD.
Get free Oncolytics Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -19,837,901 CAD
- Net income
- -18,298,703 CAD
- Operating cash flow
- -17,208,222 CAD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Oncolytics Biotech financial years